beta
IA Trial Radar
Puedo ayudarle a entender sus condiciones de salud, tratamientos o encontrar ensayos clínicos cercanos.
Nuestra herramienta de búsqueda solo admite inglés. Para búsquedas y discusiones en otros idiomas, use la IA Trial Radar o seleccione los filtros de condición médica y ubicación a continuación.
477 resultados
Mostrando los 50 primeros
 
Estado (Por defecto)
Aún No Recluta, Reclutando, Activo, No Reclutando
×
 
Intervención
GLP-1
×
 
Título del estudio
Estado
Dietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy (DINE-GLP1) NCT07313384
Reclutando
Impact GLP-1 Agonists Following Bariatric NCT06132477
Reclutando
Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity Lymphedema NCT07012642
Reclutando
GLP-1 RA on Liver OMICS in MASLD NCT06982378
Aún no recluta
Effect of Agonist GLP1 on Adipose Tissue in Patients Undergoing Bariatric Surgery (Maigrir_OT) NCT06278285
Reclutando
Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial NCT07111494
Aún no recluta
GLP-1 and Hypoglycemia NCT01858896
Activo, no reclutando
Effects of GLP-1 Formula on GLP-1 and Glucose Regulation NCT07082062
Reclutando
Effects of a GLP-1 Formula Drink on Gut Microbiota and Glycemic Control in Prediabetic Individuals NCT07089732
Aún no recluta
People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists NCT07207148
Reclutando
Identifying Changes in Food Behaviors Associated With Beginning GLP-1 Medication NCT06843512
Reclutando
Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration. NCT07297238
Aún no recluta
Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss Therapy NCT07175805
Aún no recluta
Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity (BETTER-GLP1) NCT07042672
Reclutando
Impact of GLP-1 Receptor Agonists on Patients With IPMN (IPMN-GLP1RA) NCT07014709
Aún no recluta
Combination Therapy for Alcohol Use Disorder NCT07249554
Aún no recluta
Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer NCT07314528
Aún no recluta
Evaluar el impacto del ácido poli-l-láctico en sujetos con glp1 NCT07217743
Aún no recluta
GLP1 Analogues and the Risk of Osteoarthritis NCT07360457
Aún no recluta
The Effect of GIP, GLP-1 and GLP-2 in Individuals With Genetically Altered Receptor Function (H-21044858) NCT06194955
Reclutando
Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists NCT07325435
Activo, no reclutando
Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring NCT06668935
Reclutando
Bone Metabolism in 12-21 Year Olds Undergoing GLP-1 Receptor Agonist Therapy NCT06903923
Reclutando
The Effect of Endogenous GLP-1 on Glucagon Secretion in Type 1 Diabetes (EX-HYPO) NCT07373236
Reclutando
Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity) NCT07480109
Aún no recluta
RESCUE: Interrupción de GLP-1 NCT07190794
Reclutando
Investigation of the Evolution of Gastric Emptying by Gastric Ultra Sonography in Patients Treated With GLP-1 Receptor Agonists on a 7 Days Pausing Period. NCT06388213
Aún no recluta
Assess Impact of Microdroplet Hyaluronic Acid Filler on Skin Quality in Patients on Glucagon-like Peptide-1 Agonists NCT07221461
Aún no recluta
Protective Benefits of a Clear Liquid Diet on Residual Gastric Content in Patients Taking Glucagon Like Peptide-1 Receptor (GLP-1 RA) Agonist Prior to Anesthesia NCT06654219
Reclutando
Effect of Prolonged Fasting Time on Gastric Residual Volume in Patients Taking GLP1 Receptor Agonists NCT07006142
Reclutando
Beta-cell Response to Incretin Hormones in Cystic Fibrosis NCT01851694
Reclutando
Effect of GLP-1 Receptor Agonists on Body Composition in Obesity: The Role of Dietary Protein Consumption in Muscle Mass Maintenance (LEAN-PRO GLP-1) NCT07495904
Reclutando
Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists NCT07224880
Reclutando
Semaglutide and Preoperative Residual Gastric Volumes NCT06263595
Reclutando
The Impact of GLP Medication on Colonoscopy Bowel Preparation Quality NCT07127354
Reclutando
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes (PRECIDENTD) NCT05390892
Reclutando
The Role of Islet GLP-1 in the Pathogenesis of Prediabetes NCT06967558
Reclutando
Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM NCT06256419
Reclutando
Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes (GLOW) NCT07428746
Aún no recluta
Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs (ICDDTKZ26) NCT07303556
Activo, no reclutando
Effect of a Food for Special Medical Purposes on Muscle Mass Preservation During GLP-1 RAs Weight Loss Treatment (MYO-PRESERVE) NCT07393360
Reclutando
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery NCT00992901
Reclutando
Effects of Beginning a GLP1-Agonist Therapy on Residual Gastric Content and Gastric Emptying (GLP-1) NCT06659159
Aún no recluta
Gastric Emptying in Healthy Volunteers and GLP-1 Agonist Users (aGLP1-GUS) NCT06987669
Aún no recluta
Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study (CER-4-T2D) NCT05220917
Activo, no reclutando
Insulin-Mediated Glucose Uptake and Organ Perfusion Assessed by Total-Body PET During GIP and GLP-1 Infusion NCT07398300
Reclutando
Cambios en el gusto y los hábitos alimentarios asociados con los agonistas del GLP-1 en pacientes con pérdida de peso (GLP1-TASTE) NCT07229170
Aún no recluta
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs (EXCEED) NCT05663515
Reclutando
The Effect of rs7903146 Genotype on Islet GLP-1 Production in Humans NCT06972407
Aún no recluta
Restoring Facial Volume After GLP-1 Weight Loss With Radiesse NCT07419854
Reclutando